ArticleAntimicrobial agents and chemotherapy2004
Antimicrobial susceptibility patterns among viridans group streptococcal isolates from infective endocarditis patients from 1971 to 1986 and 1994 to 2002.
Article in Antimicrobial agents and chemotherapy, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Clinical and microbiological profile of Viridans group streptococcal bacteraemia; experience from South India.Le infezioni in medicina · 2024Article
- Combinations of Daptomycin plus Ceftriaxone, but Not Ascending Daptomycin Dose-Regimens, Are Effective in Experimental Endocarditis Caused by Streptococcus mitisAntimicrobial agents and chemotherapy · 2023Article
- Antibiotic susceptibility patterns of viridans group streptococci isolates in the United States from 2010 to 2020.JAC-antimicrobial resistance · 2022Article
- Clinical features and antimicrobial susceptibility of oral bacteria isolated from the blood cultures of patients with infective endocarditis.Journal of dental sciences · 2022Article
- Prosthetic valve endocarditis due to highly beta-lactam-resistantAccess microbiology · 2022Article
- Bacterial cell membranes and their role in daptomycin resistance: A review.Frontiers in molecular biosciences · 2022Review
- Mechanistic Fingerprinting Reveals Kinetic Signatures of Resistance to Daptomycin and Host Defense Peptides inAntibiotics (Basel, Switzerland) · 2021Article
- Intravenous administration of Penicillin results in therapeutic intravitreal levels in chronic postoperative endophthalmitis.Journal of ophthalmic inflammation and infection · 2021Article
- Effectiveness of daptomycin against infective endocarditis caused by highly penicillin-resistant viridans group streptococci.IDCases · 2021Article
- Multiple Deep-seated Dentofacial Abscesses Caused by Multidrug-resistant Viridans Group Streptococci.Internal medicine (Tokyo, Japan) · 2020Article
- Strain-Specific Adaptations ofAntibiotics (Basel, Switzerland) · 2020Article
- Article
- Mutations inAntimicrobial agents and chemotherapy · 2019Article
- Article
- Pharmacokinetics of Penicillin G in Preterm and Term Neonates.Antimicrobial agents and chemotherapy · 2018Article
- Impact of High-Level Daptomycin Resistance in the Streptococcus mitis Group on Virulence and Survivability during Daptomycin Treatment in Experimental Infective Endocarditis.Antimicrobial agents and chemotherapy · 2017Article
- Perturbations of Phosphatidate Cytidylyltransferase (CdsA) Mediate Daptomycin Resistance in Streptococcus mitis/oralis by a Novel Mechanism.Antimicrobial agents and chemotherapy · 2017Article
- Article
- Phylogenetic analysis of viridans group streptococci causing endocarditis.Journal of clinical microbiology · 2008Article
- Drug susceptibility testing of clinical isolates of streptococci and enterococci by the Phoenix automated microbiology system.BMC microbiology · 2007Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To determine whether changes in antimicrobial resistance have occurred among viridans group streptococci, we retrospectively examined 50 viridans group streptococcal isolates recovered from patients with infective endocarditis over 3 decades. Resistance rates (percent resistant isolates 1971 to 1986 and 1994 to 2002) were as follows: levofloxacin, 0 and 9; penicillin and clindamycin, 0 and 4; and erythromycin and azithromycin, 11 and 26, respectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.